VKH
GHDX

Virtu KCG Holdings’s Genomic Health, Inc. GHDX Stock Holding History

Virtu KCG Holdings’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-9,033
Closed -$265K – 4024
2016
Q4 		$265K Buy
+9,033
New +$275K 0.01% 2245
2015
Q4 		– Sell
-12,114
Closed -$256K – 4129
2015
Q3 		$256K Buy
+12,114
New +$312K ﹤0.01% 2283

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Virtu KCG Holdings's GHDX Position: Q1 2017 in Review

Virtu KCG Holdings sold out of Genomic Health, Inc. (GHDX) in Q1 2017, closing a stake of 9,033 shares — an estimated $265K sold.

Virtu KCG Holdings first reported a position in GHDX in Q3 2015 and held it in 2 quarters. The position peaked at $265K in Q4 2016. 124 funds tracked by Wall St. Rank hold GHDX as of Q1 2017.

  • Virtu KCG Holdings reported no remaining Genomic Health, Inc. position as of Q1 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 9,033 Genomic Health, Inc. shares in Q1 2017, an estimated $265K.
  • Virtu KCG Holdings first reported a position in Genomic Health, Inc. in Q3 2015 and held it in 2 quarters.
  • Virtu KCG Holdings's Genomic Health, Inc. position peaked at $265K in Q4 2016.
  • 124 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q1 2017.

Based on Virtu KCG Holdings's 13F filing for Q1 2017, filed 12 May 2017.